| Project/Area Number |
15K19639
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Pediatrics
|
|---|
| Research Institution | Tokyo Women's Medical University |
|---|
Principal Investigator |
Nagai Ayako 東京女子医科大学, 医学部, 研究生 (10622160)
|
|---|
| Research Collaborator |
NAKANISHI Toshio
FURUTANI Yoshiyuki
|
|---|
| Project Period (FY) |
2015-04-01 – 2018-03-31
|
| Project Status |
Completed (Fiscal Year 2017)
|
| Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2017: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Keywords | 肺動脈性肺高血圧症 / 遺伝子変異 |
|---|
| Outline of Final Research Achievements |
In order to find novel disease-causing variants in patients with pulmonary arterial hypertension, we performed direct sequencing and multiplex ligation-dependent probe amplification to analyze 18 families with multiple affected family members with PAH. In one of the 18 families with PAH, there were no disease-causing variants already-known. Whole-exome next-generation sequencing was performed in the family, and we identified a novel variant in X gene in the family. The variant, R554L-X, revealed gain-of-function and induced decreasing nucleus p53 and p21, lower phosphorylation of nucleus p53, decreasing apoptotic hPASMCs, and increasing hPASMCs proliferation and cell viability compared to wild-type X. This study can contribute to elucidate mechanism of PAH pathogenesis.
|
